SIREN : 494068117
ACKERMANN MARIE CLAIRE is a French company founded 19 years ago, specialized in the sector Activité des médecins généralistes. Based in DURMENACH (68480), this company of category PME shows in 2024 a revenue of 232 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-09-19
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
Aucun signal de fragilité majeur : rentabilité positive et structure financière équilibrée.
In summary, ACKERMANN MARIE CLAIRE combines a growing business with positive profitability. Its financial structure is solid, with debt well contained relative to its sector.
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 232 076 € | 232 157 € | 224 986 € | 219 272 € | 207 502 € | 208 975 € | 199 282 € | 200 813 € | 205 112 € |
| Net income | 38 908 € | 29 854 € | 40 573 € | 44 034 € | 40 272 € | 41 620 € | 36 844 € | 37 806 € | 26 971 € |
| EBITDA | 48 335 € | 40 345 € | 55 886 € | 60 563 € | 52 221 € | 57 376 € | 48 782 € | 52 319 € | 37 848 € |
| Net margin | 16.8% | 12.9% | 18.0% | 20.1% | 19.4% | 19.9% | 18.5% | 18.8% | 13.1% |
In 2024, ACKERMANN MARIE CLAIRE achieves revenue of 232 k€. Revenue is growing positively over 9 years (CAGR: +2.8%). Slight decline of -0% vs 2023. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 48 k€, representing 20.8% of revenue. Positive scissor effect: EBITDA margin improves by +3.4 pts, sign of improved operational efficiency. This ratio is more favorable than the sector median (14.8%). Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 39 k€, i.e. 16.8% of revenue. This profit can be retained or distributed to shareholders.
232 076 €
231 285 €
48 335 €
42 395 €
38 908 €
20.8%
The debt ratio (= Financial debt / Equity x 100) stands at 9%. This ratio is more favorable than the sector median (12.8%). Financial autonomy (= Equity / Total assets x 100) reaches 89%. Compared with its sector, this ratio places the company among the best positioned (sector median: 63.3%). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.6 years of cash flow to repay all financial debt. This ratio is slightly less favorable than the sector median (0.5 years). Cash flow represents 17.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This ratio is more favorable than the sector median (11.0%).
9.35%
88.67%
17.16%
0.63
10.1%
In 2024, the debt ratio of ACKERMANN MARIE CLAIRE (9.3%) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of ACKERMANN MARIE CLAIRE (88.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of ACKERMANN MARIE CLAIRE (0.63) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 22.24. Compared with its sector, this ratio places the company among the best positioned (sector median: 3.3).
22.24
0.0
In 2024, the liquidity ratio of ACKERMANN MARIE CLAIRE (22.24) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of ACKERMANN MARIE CLAIRE (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 9 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 22 days. Favorable situation: supplier credit is longer than customer credit by 13 days. Overall, WCR represents 48 days of revenue, i.e. 31 k€ to permanently finance. Between 2021 and 2024, WCR worsened by 24 days of revenue, signaling an increased financing need.
30 778 €
9 j
22 j
0 j
48 j
Based on 274 transactions of similar company sales (all years), the value of ACKERMANN MARIE CLAIRE is estimated at 147 282 € (range 54 078€ - 319 757€). With an EBITDA of 48 335€, the sector multiple of 3.6x is applied. The price/revenue ratio is 0.43x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 274 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare ACKERMANN MARIE CLAIRE with other companies in the same sector:
Voir toutes les statistiques du secteur Activité des médecins généralistes
Largest companies by revenue in the sector Activité des médecins généralistes:
Largest companies by revenue in the department Haut-Rhin:
The revenue of ACKERMANN MARIE CLAIRE in 2024 is 232 k€.
Yes, ACKERMANN MARIE CLAIRE generated a net profit of 39 k€ in 2024.
The headquarters of ACKERMANN MARIE CLAIRE is located in DURMENACH (68480), in the department Haut-Rhin.
The tax return of ACKERMANN MARIE CLAIRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
ACKERMANN MARIE CLAIRE operates in the sector Activité des médecins généralistes (NAF code 86.21Z). See the 'Sector positioning' section above to compare the company with its competitors.